Active Ingredient: LAROTRECTINIB SULFATE
Proprietary Name: VITRAKVI
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210861
Product Number: 002
Approval Date: Nov 26, 2018
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information